Antigen cancer therapeutics. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Cell Line, Tumor Cell Line HCT116 Cells Tumor Cells, Cultured T-Lymphocytes HeLa Cells Cells, Cultured Neoplastic Stem Cells Immune Sera B-Lymphocytes Lymph Nodes Dendritic Cells Prostate Lymphocytes Spleen T-Lymphocytes, Cytotoxic Breast

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic

Diseases32

Neoplasms Prostatic Neoplasms Breast Neoplasms Lung Neoplasms Cell Transformation, Neoplastic Ovarian Neoplasms Colonic Neoplasms Disease Models, Animal Neovascularization, Pathologic Stomach Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Disease Progression Genetic Predisposition to Disease Uterine Cervical Neoplasms Carcinoma, Squamous Cell Colorectal Neoplasms Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma Rectal Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Melanoma Liver Neoplasms Endometrial Neoplasms Esophageal Neoplasms Neoplasms, Experimental Head and Neck Neoplasms Skin Neoplasms Carcinoma, Small Cell

Chemicals and Drugs93

Antigens Antineoplastic Agents Antigens, Bacterial Antigens, Neoplasm Antigens, Surface Antigens, Viral Antibodies, Monoclonal Neoplasm Proteins Antigens, Protozoan RNA, Small Interfering Protein Kinase Inhibitors Antigens, Polyomavirus Transforming HLA Antigens Antigens, CD Enzyme Inhibitors Prostate-Specific Antigen Carcinoembryonic Antigen Small Molecule Libraries Antigens, Fungal Antigens, Helminth Tumor Suppressor Protein p53 RNA, Messenger Inhibitor of Apoptosis Proteins H-2 Antigens Receptor, erbB-2 Cancer Vaccines Antigens, Viral, Tumor Peptides Histone Deacetylase Inhibitors Proliferating Cell Nuclear Antigen HLA-DR Antigens Receptors, Antigen, T-Cell Antigens, Tumor-Associated, Carbohydrate Epitopes Receptor, Epidermal Growth Factor Histocompatibility Antigens HSP90 Heat-Shock Proteins Histocompatibility Antigens Class II Benzamides Angiogenesis Inhibitors Tumor Markers, Biological Receptors, Antigen, B-Cell O Antigens Immunoglobulin G HLA-A2 Antigen Antigens, CD15 Pyrimidines Piperazines Proto-Oncogene Proteins c-bcl-2 Antigens, CD8 Protein-Serine-Threonine Kinases Antigens, CD3 HLA-A Antigens Blood Group Antigens Hepatitis B Surface Antigens Histocompatibility Antigens Class I Receptors, Estrogen Antigens, CD4 Antibodies Receptors, Antigen Antigens, CD45 Recombinant Proteins HLA-D Antigens Hepatitis B Antigens DNA, Neoplasm Antigens, Differentiation Antigens, CD1 Antibodies, Bacterial Ki-67 Antigen Immune Sera HLA-B Antigens CA-125 Antigen MicroRNAs MART-1 Antigen Antineoplastic Agents, Phytogenic Membrane Proteins Antigens, CD80 Fluorouracil Nuclear Proteins Tamoxifen CA-19-9 Antigen DNA-Binding Proteins Receptors, Progesterone HIV Antigens Autoantigens Cisplatin Antineoplastic Agents, Hormonal Glycoproteins Epstein-Barr Virus Nuclear Antigens Recombinant Fusion Proteins Drug Carriers Antigens, CD19 Interferon-gamma

Analytical, Diagnostic and Therapeutic Techniques and Equipment58

Drug Delivery Systems Molecular Targeted Therapy Xenograft Model Antitumor Assays Drug Design Clinical Trials as Topic Early Detection of Cancer Drug Discovery Drug Screening Assays, Antitumor Models, Biological Therapeutics Neoplasm Transplantation Blotting, Western Drug Evaluation, Preclinical Transplantation, Heterologous Immunotherapy Flow Cytometry Transfection Tumor Burden Inhibitory Concentration 50 Disease Models, Animal Enzyme-Linked Immunosorbent Assay Genetic Therapy Reverse Transcriptase Polymerase Chain Reaction Sensitivity and Specificity Prognosis Immunoenzyme Techniques Survival Analysis Gene Expression Profiling Fluorescent Antibody Technique Models, Molecular Survival Rate Antineoplastic Combined Chemotherapy Protocols Lymphocyte Activation Retrospective Studies Follow-Up Studies Risk Polymerase Chain Reaction Prospective Studies Neoplasm Staging Immunohistochemistry Combined Modality Therapy Registries Risk Assessment Immunization Disease-Free Survival Oligonucleotide Array Sequence Analysis Odds Ratio Reproducibility of Results Immunoblotting Risk Factors Chemotherapy, Adjuvant Predictive Value of Tests Kaplan-Meier Estimate Neoplasms, Experimental Multivariate Analysis Drug Carriers Treatment Outcome Questionnaires

Psychiatry and Psychology1

Phenomena and Processes46

Gene Expression Regulation, Neoplastic Apoptosis Signal Transduction Drug Resistance, Neoplasm Cell Proliferation Cell Survival Mutation RNA Interference Amino Acid Sequence Transfection Inhibitory Concentration 50 Dose-Response Relationship, Drug Cell Division Protein Binding Down-Regulation Drug Synergism Phosphorylation Protein Structure, Tertiary DNA Damage Sensitivity and Specificity Base Sequence Genetic Predisposition to Disease Antibody Specificity Structure-Activity Relationship Cross Reactions Binding Sites Lymphocyte Activation Risk Antigen-Antibody Reactions Antibody Formation Cell Movement Phenotype Genotype Gene Expression Time Factors DNA Methylation Cell Cycle Promoter Regions, Genetic Up-Regulation Odds Ratio Polymorphism, Genetic Genetic Vectors Gene Silencing Cell Growth Processes Cell Differentiation Molecular Weight

Disciplines and Occupations6

Drug Design Nanomedicine Drug Discovery Immunohistochemistry Pharmacology, Clinical Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture2

Nanomedicine Nanoparticles

Information Science6

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate Registries Questionnaires

Named Groups1

Health Care23

Clinical Trials as Topic Pharmacy and Therapeutics Committee Sensitivity and Specificity Survival Analysis Survival Rate National Cancer Institute (U.S.)Retrospective Studies Follow-Up Studies Risk Prospective Studies Age Factors Registries Risk Assessment Immunization Disease-Free Survival Odds Ratio Reproducibility of Results Risk Factors Predictive Value of Tests Kaplan-Meier Estimate Multivariate Analysis Treatment Outcome Questionnaires

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Neoplasms Antigens Antineoplastic Agents Antigens, Bacterial Antigens, Neoplasm Cell Line, Tumor Antigens, Surface Drug Delivery Systems Molecular Targeted Therapy Antigens, Viral Xenograft Model Antitumor Assays Antibodies, Monoclonal Drug Design Mice, Nude Gene Expression Regulation, Neoplastic Prostatic Neoplasms Breast Neoplasms Apoptosis Signal Transduction Drug Resistance, Neoplasm Cell Proliferation Nanomedicine Clinical Trials as Topic Neoplasm Proteins Early Detection of Cancer Drug Discovery Lung Neoplasms Nanoparticles Antigens, Protozoan RNA, Small Interfering Protein Kinase Inhibitors Drug Screening Assays, Antitumor Antigens, Polyomavirus Transforming Cell Survival Models, Biological HLA Antigens Molecular Sequence Data Antigens, CD Enzyme Inhibitors Therapeutics Prostate-Specific Antigen Carcinoembryonic Antigen Small Molecule Libraries Cell Transformation, Neoplastic Antigens, Fungal Neoplasm Transplantation Blotting, Western Mutation RNA Interference Cell Line Antigens, Helminth Tumor Suppressor Protein p53 Drug Evaluation, Preclinical RNA, Messenger Inhibitor of Apoptosis Proteins Ovarian Neoplasms Transplantation, Heterologous H-2 Antigens Amino Acid Sequence Immunotherapy Receptor, erbB-2 HCT116 Cells Colonic Neoplasms Flow Cytometry Transfection Tumor Burden Inhibitory Concentration 50 Dose-Response Relationship, Drug Cancer Vaccines Disease Models, Animal Tumor Cells, Cultured Neovascularization, Pathologic Antigens, Viral, Tumor Mice, SCID Stomach Neoplasms Cell Division Mice, Inbred BALB C Neoplasm Metastasis Peptides Protein Binding Histone Deacetylase Inhibitors Down-Regulation Proliferating Cell Nuclear Antigen Enzyme-Linked Immunosorbent Assay HLA-DR Antigens Genetic Therapy Receptors, Antigen, T-Cell Antigens, Tumor-Associated, Carbohydrate Neoplasm Invasiveness Pancreatic Neoplasms Epitopes Receptor, Epidermal Growth Factor Histocompatibility Antigens HSP90 Heat-Shock Proteins Pharmacy and Therapeutics Committee T-Lymphocytes Histocompatibility Antigens Class II Benzamides Drug Synergism Reverse Transcriptase Polymerase Chain Reaction

No FAQ available that match "antigen cancer therapeutics"